422 results on '"Kottschade, Lisa"'
Search Results
2. Diagnosis and Management of Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
3. Comparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer -- The PRO-TECT Trial
4. Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy
5. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers
6. Incidence and Effect Duration of Immune Checkpoint Inhibitor-Related Pancreas Adverse Events.
7. Identification and Characterization of Immune Checkpoint Inhibitor–Induced Toxicities From Electronic Health Records Using Natural Language Processing
8. A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
9. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
10. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
11. Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program
12. Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study
13. Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitor Therapy
14. The Future of Immunotherapy in the Treatment of Cancer
15. Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
16. A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
17. Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma
18. Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine
19. Data from SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
20. Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era
21. Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
22. Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.
23. Skin Cancers
24. Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
25. Supplementary Table S4 from SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
26. Supplementary Figure S1 from SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
27. Abstract CT207: Phase I trial of vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 (VSV-IFNb-TYRP1) in metastatic ocular melanoma
28. Abstract 6644: Investigating the effect of immune checkpoint inhibitors (ICI) on ovarian function in young patients with melanoma
29. SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
30. Plasma Methylated DNA Markers for Melanoma Surveillance.
31. Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers.
32. Sinonasal mucosal melanoma: An analysis of treatment‐related adverse events and associated factors
33. 785 A phase I study of intralymphatic (IL) administration of ipilimumab (IPI) with intravenous nivolumab (NIVO) using the Sofusa® DoseConnect™ device in patients with advanced melanoma
34. 1274 Identification and characterization of immune checkpoint inhibitor induced immune-related adverse events from electronic health records using natural language processing techniques
35. A mixed-methods study to identify key priorities around improving team-based care coordination for patients receiving combination IV and oral systemic anti-cancer therapy.
36. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
37. Nursing's Presence in the Changing Cooperative Group Setting
38. Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience
39. NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma
40. Sinonasal mucosal melanoma: An analysis of treatment‐related adverse events and associated factors.
41. Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors
42. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance)
43. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer
44. SALVO: Single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma.
45. Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients
46. Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation
47. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma at Major Referral Centers
48. Immune checkpoint inhibitor-induced hypophysitis: lessons learnt from a large cancer cohort
49. Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial.
50. Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.